Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Essa Pharma Inc. EPIX

ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:EPIX)

Fundamentals Snapshot (NDAQ:EPIX)

Opinion & Analysis (NDAQ:EPIX)

No current opinion is available.

Bullboard Posts (NDAQ:EPIX)

ESSA has begun recruiting for its phase 1/2 combo trial

ESSA has filed an update on clinicaltrials.gov announcing that it has begun recruiting patients for its phase 1/2 combination trial (EPI...
allison5120 - October 24, 2021

Evercore SII 3rd Annual HealthCONx Conference

ESSA Pharma to Participate at Evercore SII 3rd Annual HealthCONx Conference       HOUSTON and...
SilentRiver - November 25, 2020

Upcoming Investor Conferences

ESSA Pharma to Participate in Upcoming Investor Conferences       HOUSTON and VANCOUVER, BC,&...
SilentRiver - November 11, 2020

RE:Delisting from the TSX-V

Can someone tell me how that affects shares owned through the tsx? What happens to them? Thanks
SilentRiver - October 27, 2020

Delisting from the TSX-V

ESSA Pharma Inc. Announces Delisting from the TSX-V       HOUSTON and VANCOUVER, BC, Oct...
SilentRiver - October 27, 2020

Presents Therapeutic Potential of EPI-7386

ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium HOUSTON and VANCOUVER, BC, ...
SilentRiver - October 26, 2020